LAB – standard biotools inc. (US:NASDAQ)

News

Standard BioTools Completes Sale of SomaLogic to Illumina
Standard BioTools (NASDAQ:LAB) shareholders have endured a 76% loss from investing in the stock five years ago [Yahoo! Finance]
Standard BioTools (NASDAQ:LAB) had its "sell (d-)" rating reaffirmed by analysts at Weiss Ratings.
Alamar Biosciences Announces Close of Oversubscribed Convertible Notes Financing and Expansion of Leadership Team [Yahoo! Finance]
Standard BioTools Announces Preliminary Fourth Quarter and Full Year 2025 Revenue
Show more
Live Event: Join our next subscriber-only event: "The Data Driven Investor"
Register for our next upcoming LIVE training session, which will be hosted on Tuesday April 24th at 08:00 PM EST (New York Time).
Get your questions answered during the Q & A session.
For any support questions, contact our team: support@newsquantified.com